Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:95 |
---|---|
Enthalten in: |
Journal of acquired immune deficiency syndromes (1999) - 95(2024), 5 vom: 15. März, Seite e8-e11 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Dorward, Jienchi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alkynes |
---|
Anmerkungen: |
Date Completed 18.03.2024 Date Revised 24.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1097/QAI.0000000000003385 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369791762 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369791762 | ||
003 | DE-627 | ||
005 | 20240324235126.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240316s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/QAI.0000000000003385 |2 doi | |
028 | 5 | 2 | |a pubmed24n1344.xml |
035 | |a (DE-627)NLM369791762 | ||
035 | |a (NLM)38489494 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Dorward, Jienchi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.03.2024 | ||
500 | |a Date Revised 24.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a dolutegravir |2 NLM | |
650 | 7 | |a DKO1W9H7M1 |2 NLM | |
650 | 7 | |a efavirenz |2 NLM | |
650 | 7 | |a JE6H2O27P8 |2 NLM | |
650 | 7 | |a Oxazines |2 NLM | |
650 | 7 | |a Benzoxazines |2 NLM | |
650 | 7 | |a Anti-Retroviral Agents |2 NLM | |
650 | 7 | |a Heterocyclic Compounds, 3-Ring |2 NLM | |
650 | 7 | |a Pyridones |2 NLM | |
650 | 7 | |a Anti-HIV Agents |2 NLM | |
650 | 7 | |a Alkynes |2 NLM | |
650 | 7 | |a Cyclopropanes |2 NLM | |
650 | 7 | |a Piperazines |2 NLM | |
700 | 1 | |a Sookrajh, Yukteshwar |e verfasserin |4 aut | |
700 | 1 | |a Lessells, Richard |e verfasserin |4 aut | |
700 | 1 | |a Bulo, Elliot |e verfasserin |4 aut | |
700 | 1 | |a Bodley, Nicola |e verfasserin |4 aut | |
700 | 1 | |a Singh, Lavanya |e verfasserin |4 aut | |
700 | 1 | |a Moodley, Pravikrishnen |e verfasserin |4 aut | |
700 | 1 | |a Samsunder, Natasha |e verfasserin |4 aut | |
700 | 1 | |a Drain, Paul K |e verfasserin |4 aut | |
700 | 1 | |a Hayward, Gail |e verfasserin |4 aut | |
700 | 1 | |a Butler, Christopher C |e verfasserin |4 aut | |
700 | 1 | |a Garrett, Nigel |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of acquired immune deficiency syndromes (1999) |d 1999 |g 95(2024), 5 vom: 15. März, Seite e8-e11 |w (DE-627)NLM101679912 |x 1944-7884 |7 nnns |
773 | 1 | 8 | |g volume:95 |g year:2024 |g number:5 |g day:15 |g month:03 |g pages:e8-e11 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/QAI.0000000000003385 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 95 |j 2024 |e 5 |b 15 |c 03 |h e8-e11 |